0001179110-13-003143.txt : 20130220 0001179110-13-003143.hdr.sgml : 20130220 20130220173543 ACCESSION NUMBER: 0001179110-13-003143 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20130215 FILED AS OF DATE: 20130220 DATE AS OF CHANGE: 20130220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: D-322 AP6D CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 8479376100 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Magill Paul K CENTRAL INDEX KEY: 0001561122 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 13627992 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: AP6C-1N CITY: ABBOTT PARK STATE: IL ZIP: 60064-6092 4 1 edgar.xml FORM 4 - X0306 4 2013-02-15 0 0000001800 ABBOTT LABORATORIES ABT 0001561122 Magill Paul K 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-6092 0 1 0 0 Senior Vice President Common shares without par value 2013-02-15 4 A 0 23000 0 A 33000 D Option (right to buy) 34.94 2013-02-15 4 A 0 119700 0 A 2014-02-15 2023-02-14 Common shares 119700 119700 D These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 39,900 on 2/15/2014, 39,900 on 2/15/2015, and 39,900 on 2/15/2016. John A. Berry, attorney-in-fact for Paul K. Magill 2013-02-20 EX-24 2 ex24magill.txt Exhibit 24.1 POWER OF ATTORNEY The undersigned constitutes and appoints HUBERT L. ALLEN,JOHN A. BERRY and JESSICA H. PAIK,and each of them individually, as the undersigned's true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for the undersigned and in the undersigned's name, place and stead, to prepare and sign any and all Securities and Exchange Commission ("SEC") Notices of Proposed Sales of Securities pursuant to Rule 144 under the Securities Act of 1933 on Form 144, all SEC statements on Forms 3, 4 and 5 as required under Section 16(a) of the Securities Exchange Act of 1934, including a Form ID and any other documents necessary to obtain codes and passwords necessary to make electronic filings, and any amendments to such forms, and to file the same with all exhibits thereto, and other documents in connection therewith, with the SEC, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite, necessary or desirable to be done under said Rule 144 and Section 16(a), as fully for all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent may lawfully do or cause to be done by virtue hereof. A copy of this power of attorney shall be filed with the SEC. The authorization set forth above shall continue in full force and effect until the undersigned is no longer required to file Forms 144, 3, 4, or 5 or if earlier, until the undersigned revokes such authorization by written instructions to the attorney-in-fact. Date: January 7, 2013 /s/ Paul K. Magill Signature of Reporting Person Paul K. Magill Abbott Laboratories 100 Abbott Park Road Abbott Park, IL 60064